Pay in 4 interest-free payments of $7.26 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
Dose increases usually occur when: You tolerate the current dose well Digestive symptoms are minimal Appetite suppression begins to level out You are progressing comfortably Your titration may slow down if you experience: Persistent nausea Vomiting Dizziness or fatigue Difficulty maintaining adequate nutrition Rapid or uncomfortable early weight loss A slower titration is completely normal and often improves long-term success
Some women experience cycles extending beyond 35 days or shortening to less than 21 days
The most reliable path to coverage is a diagnosis of type 2 diabetes, which is the FDA-approved indication for several GLP-1 medications
According to Mayo Clinic, these drugs are among the most effective tools available today for managing both blood sugar and body weight in adults
A Mounjaro is covered by insurance as a treatment for type 2 diabetes
Perhaps most notably for weight management, GLP-1 receptor agonists slow gastric emptying and act on appetite centres in the brain, leading to increased satiety and reduced food intake
